Friday, December 27, 2024
Home 2022

Yearly Archives: 2022

Courtesy Ben Mills
Biotech News

Glutathione: The “Mother” of all Antioxidants…

Editor / Curator -
Biotech News

Revive Therapeutics (RVVTF) Regulatory Update Archive.

Editor / Curator -
Stand Down

Stand Down. “A Super Bubble” says Jeremy Grantham, the “Day of...

Editor / Curator -
Revive Therapeutics
2022 Watch List

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Editor / Curator -
Revive Therapeutics $RVVTF
All News

Amazing Sales of Paxlovid (CBS News).

Editor / Curator -
Revive therapeutics
2022 Watch List

Our Best Risk to Reward Idea Ever?

Editor / Curator -
Immunix Bio
2022 Watch List

ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.

Editor / Curator -
2022 Watch List

Revive Therapeutics Updates, on Phase III Clinical Trial!

Editor / Curator -
Biotech News

Revive Therapeutics (RVVTF) Provides Update of Psilocybin Pharmaceutical Programs

Editor / Curator -
Fuqua Professor David Ridley
Biotech News

Everything You Need to Know About FDA’s Priority Review Vouchers Worth...

Editor / Curator -
1...111213Page 12 of 13

Latest article

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.